These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2918502)

  • 1. Long acting dihydropyridine calcium antagonists. 2. 2-[2-Aminoheterocycloethoxy]methyl derivatives.
    Arrowsmith JE; Campbell SF; Cross PE; Burges RA; Gardiner DG
    J Med Chem; 1989 Mar; 32(3):562-8. PubMed ID: 2918502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting dihydropyridine calcium antagonists. 3. Synthesis and structure-activity relationships for a series of 2-[(heterocyclylmethoxy)methyl] derivatives.
    Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
    J Med Chem; 1989 Oct; 32(10):2381-8. PubMed ID: 2795609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting dihydropyridine calcium antagonists. 4. Synthesis and structure-activity relationships for a series of basic and nonbasic derivatives of 2-[(2-aminoethoxy)methyl]-1,4-dihydropyridine calcium antagonists.
    Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
    J Med Chem; 1990 Feb; 33(2):585-91. PubMed ID: 2153819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting dihydropyridine calcium antagonists. 5. Synthesis and structure-activity relationships for a series of 2-[[(N-substituted-heterocyclyl)ethoxy]methyl]-1,4-dihydropyridine calcium antagonists.
    Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
    J Med Chem; 1990 Jun; 33(6):1805-11. PubMed ID: 2342074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting dihydropyridine calcium antagonists. 6. Structure-activity relationships around 4-(2,3-dichlorophenyl)-3-(ethoxycarbonyl)-2-[(2-hydroxyethoxy)methyl]-5 -(methoxycarbonyl)-6-methyl-1,4-dihydropyridine.
    Alker D; Campbell SF; Cross PE
    J Med Chem; 1991 Jan; 34(1):19-24. PubMed ID: 1992115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coumarin 1,4-dihydropyridine derivatives.
    Valenti P; Rampa A; Budriesi R; Bisi A; Chiarini A
    Bioorg Med Chem; 1998 Jun; 6(6):803-10. PubMed ID: 9681146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety.
    Budriesi R; Bisi A; Ioan P; Rampa A; Gobbi S; Belluti F; Piazzi L; Valenti P; Chiarini A
    Bioorg Med Chem; 2005 May; 13(10):3423-30. PubMed ID: 15848754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SAR studies in the field of Ca-antagonists: 2-substituted 1,4-dihydropyridines with a xanthone backbone.
    Bisi A; Budriesi R; Chiarini A; Rampa A; Valenti P
    Farmaco; 1993 Nov; 48(11):1491-502. PubMed ID: 8110362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorenone and benzophenone 1,4-dihydropyridine derivatives with cardiodepressant activity.
    Rampa A; Budriesi R; Bisi A; Chiarini A; Valenti P
    Arzneimittelforschung; 1992 Nov; 42(11):1284-7. PubMed ID: 1492840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents.
    Arrowsmith JE; Campbell SF; Cross PE; Stubbs JK; Burges RA; Gardiner DG; Blackburn KJ
    J Med Chem; 1986 Sep; 29(9):1696-702. PubMed ID: 2943898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimeric 1,4-dihydropyridines as calcium channel antagonists.
    Joslyn AF; Luchowski E; Triggle DJ
    J Med Chem; 1988 Aug; 31(8):1489-92. PubMed ID: 2840498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates.
    Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1996 Apr; 46(4):374-7. PubMed ID: 8740081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological profile of some chloroxanthone-1, 4-dihydropyridine derivatives.
    Bisi A; Budriesi R; Rampa A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1996 Sep; 46(9):848-51. PubMed ID: 8876931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities.
    Liang JC; Yeh JL; Wang CS; Liou SF; Tsai CH; Chen IJ
    Bioorg Med Chem; 2002 Mar; 10(3):719-30. PubMed ID: 11814861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 2-amino-1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having N,N-dialkylaminoalkoxycarbonyl groups at 3- and/or 5-position.
    Kobayashi T; Inoue T; Nishino S; Fujihara Y; Oizumi K; Kimura T
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):797-817. PubMed ID: 7553967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of some 1,4-dihydropyridine derivatives and their calcium antagonistic activity.
    Safak C; Sahin I; Sunal R
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):119-22. PubMed ID: 2334450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationships.
    Sircar I; Gregor EK; Anderson KR; Haleen SJ; Shih YH; Weishaar RE; Steffen RP; Pugsley TA; Taylor MD
    J Med Chem; 1991 Jul; 34(7):2248-60. PubMed ID: 2066997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship studies in the field of calcium antagonists. Xanthone 1,4-dihydropyridines bearing a 2,3-lactone ring.
    Rampa A; Budriesi R; Bisi A; Fabbri G; Barili PL; Chiarini A; Valenti P
    Arzneimittelforschung; 1995 Sep; 45(9):957-62. PubMed ID: 7488312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
    Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
    Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
    J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.